Background
==========

Dysnatremia, a disorder of sodium concentration, is common not only in critically ill patients but also hospitalized patients, and it confers increased risk for adverse outcomes \[[@b1-medscimonit-23-2408]\]. The prevalence of dysnatremia in the intensive care unit (ICU) ranges from 6.9 to 17.7%, and varies according to the time of onset, the threshold for diagnosis, and the population being assessed \[[@b2-medscimonit-23-2408]\]. Except for hyponatremia in heart failure \[[@b3-medscimonit-23-2408],[@b4-medscimonit-23-2408]\] and cirrhosis \[[@b5-medscimonit-23-2408]\], there have been rare reports of dysnatremia in hospitalized patients. Substantial additional work is still required to determine the actual occurrence of dysnatremia in clinical settings.

Dysnatremia at admission, including hyponatremia \[[@b6-medscimonit-23-2408]\] and hypernatremia \[[@b7-medscimonit-23-2408]\], is an independent risk factor for mortality. Even slightly abnormal sodium levels are independently associated with poor outcomes \[[@b2-medscimonit-23-2408],[@b8-medscimonit-23-2408]\]. However, hospital-acquired (HA) dysnatremia may be more lethal than community-acquired (CA) dysnatremia \[[@b9-medscimonit-23-2408]\], and there may be significant differences in the clinical characteristics, outcomes, and economic burdens between them \[[@b10-medscimonit-23-2408],[@b11-medscimonit-23-2408]\]. If iatrogenic pathogenic factors are avoided, and high-risk patients are identified and treated properly, the incidence of hospital-acquired dysnatremia can be decreased.

Although a recent study \[[@b12-medscimonit-23-2408]\] showed that the impact of sodium correction on mortality was not significant in the presence of multiple comorbidities or severe diseases, the correction of dysnatremia is another important factor influencing the prognosis \[[@b13-medscimonit-23-2408]\]. About 3.6 to 6.4% of ICU patients developed both hypo- and hypernatremia during hospitalization \[[@b14-medscimonit-23-2408]\]; this mixed dysnatremia may be induced by improper correction and is associated with mortality rates of up to 42% \[[@b15-medscimonit-23-2408]\]. Persistent hyponatremia was an independent predictor of death in heart failure patients, but whether persistent dysnatremia predicts higher mortality than improved ones has not been investigated in hospitalized patients.

This study aimed to describe the prevalence of dysnatremia in various underlying diseases, to evaluate the impact of different dysnatremia on outcomes, and to identify high-risk patients who may benefit from effective prevention and proper correction.

Material and Methods
====================

Study design and data collection
--------------------------------

This study prospectively enrolled all adult patients admitted consecutively to Zhongshan Hospital, Fudan University in Shanghai, China, between October 1, 2014 and September 30, 2015. All the data were collected from the electronic medical record database of this university hospital. The data included demographics, categories of underlying diseases, and laboratory values, including electrolyte status at admission and during hospitalization. The primary outcome was hospital mortality, while the incidence of acute kidney injury (AKI), the length of hospital stay, and hospital costs were also recorded as secondary outcomes. This study was approved by the Institutional Review Board of the Ethics Committee, Zhongshan Hospital, Fudan University, Shanghai China. As an observational survey, the requirement for informed consent was waived. The patient records and information were anonymized and de-identified before analysis.

Definitions and calculation
---------------------------

Hyponatremia and hypernatremia were defined according to the reference range provided by the Central Laboratory (normal range: 137\~147mmol/L). Mixed dysnatremia was defined as both hyponatremia and hypernatremia during hospitalization in the same patient \[[@b16-medscimonit-23-2408]\]. It was defined as "hypo- to hyper-" mixed dysnatremia if hyponatremia occurred before hypernatremia, and "hyper- to hypo-" if not. CA-dysnatremia was diagnosed when dysnatremia happened at admission, HA-dysnatremia was defined when dysnatremia occurred after 24 h of hospitalization \[[@b11-medscimonit-23-2408]\], persistent dysnatremia was any degree of dysnatremia which persisted until discharge or death, and if not, improved dysnatremia was defined. We defined acute kidney injury (AKI) according to the Kidney Disease: Improving Global Outcomes (KDIGO) criteria \[[@b17-medscimonit-23-2408]\]: an increase in serum creatinine (SCr) ≥26.5 μmol/L (0.3 mg/dl) within 48 h or an increase in SCr to ≥1.5 times baseline known or presumed to have occurred within the prior 7 days. We did not consider the urine output for unavailable data. All samples were analyzed in our Central Laboratory. The anion gap (AG) was calculated by the standard formula \[[@b18-medscimonit-23-2408]\]: AG=\[Na^+^\]--\[Cl^−^\]--\[HCO~3~^−^\], with an elevated AG defined as greater than or equal to 16 mmol/L. Calculated osmolality was=2×(\[Na^+^\]+\[K^+^\])+\[glucose\]+\[urea\], with the normal range from 280 to 310 mOsm/L. Hyperkalemia, hypokalemia, hyperchloremia, hypochloremia, hypercalcemia, hypocalcemia, hyperphosphatemia, hypophosphatemia, hypermagnesemia, hypomagnesemia, hyperuricemia, and hypouricemia were defined according to the reference ranges provided by the Central Laboratory.

Statistical methods
-------------------

The data were analyzed using SPSS version 24.0 software (SPSS, Chicago, IL, USA). Continuous variables are presented as mean ± standard deviation (SD) if they were statistically normally distributed and categorical variables as numbers and percentages. For the continuous variables, data were analyzed using the *t* test, analysis of variance (ANOVA) (post hoc analysis of LSD between 2 groups), Mann-Whitney test, or Kruskal--Wallis test, depending on their distribution and number of variables. The chi-squared (χ^2^) test was used to compare categorical variables. Kaplan-Meier survival curves stratified by dysnatremia categories were plotted and compared using a signed log-rank test. Multiple binary logistic regression models with the Wald forward stepwise method were used to assess the independent risk factors for hospital mortality, and the results are presented as odds ratios (ORs) and 95% confidence intervals (CIs). Three multiple logistic regression models were used according to different classification methods of dysnatremia, and further subgroup analyses were conducted. We also used multinomial logistic regression analysis to identify risk factors for developing HA-dysnatremia and persistent dysnatremia. Normonatremia was the reference of HA-dysnatremia and improved dysnatremia as the reference of persistent dysnatremia. A *P-*value \<0.05 was deemed to indicate statistical significance.

Results
=======

Demographic and baseline clinical characteristics
-------------------------------------------------

The study flowchart is presented in [Figure 1](#f1-medscimonit-23-2408){ref-type="fig"}. We included 90 889 patients in this study after the screening. The median age was 59 years old (inter-quartile range \[IQR\]: 49--67), and 60.9% of the included patients were males. The underlying diseases were cardiovascular (17.8%), cancer (14.7%), general surgery (11.9%), digestive (11.1%), urinary and renal (7.6%), cardiothoracic surgery (7.3%), pulmonary (6.8%), orthopedic surgery (3.8%), endocrine (3.0%), hematological (3.0%), neurological (2.9%), obstetrics and gynecology (2.3%), and others (7.9%). According to the serum sodium levels during hospitalization, the included subjects were divided into 4 groups: hyponatremia (16.8%), normonatremia (81.1%), hypernatremia (1.9%), and mixed dysnatremia (0.3%). In the hyponatremia group, 7059 patients (46.3%) developed hyponatremia at admission and 8180 patients (53.7%) after 24 h of hospitalization, while 5214 patients (34.2%) improved and 10 025 patients (65.8%) remained persistent. In the hypernatremia group, 1687 patients were divided into community-acquired (n=850, 50.4%) and hospital-acquired (n=837, 49.6%) hypernatremia, while 859 patients (50.9%) had improved hypernatremia and 828 patients (49.1%) had persistent hypernatremia. Mixed dysnatremia patients were also divided into "hypo- to hyper-" group (n=102) and "hyper- to hypo-" group (n=183) according to the sequence of dysnatremia.

Characteristics of the study subjects are listed in [Tables 1](#t1-medscimonit-23-2408){ref-type="table"}[](#t2-medscimonit-23-2408){ref-type="table"}--[3](#t3-medscimonit-23-2408){ref-type="table"}. As described in [Table 1](#t1-medscimonit-23-2408){ref-type="table"}, patients in the 3 dysnatremia groups were older, had higher white blood cell counts (WBC), blood urea nitrogen (BUN), serum uric acid (SUA), and AG, had lower albumin, hemoglobin, and carbon dioxide combining power (CO~2~CP), and had more severe liver injury at admission than patients in the normonatremia group. [Table 2](#t2-medscimonit-23-2408){ref-type="table"} shows that patients in the HA-hyponatremia were younger, had a higher body mass index (BMI), hemoglobin, albumin, SCr, and SUA, had lower WBC and glucose, and had better liver function than patients in the CA-hyponatremia group. HA-hypernatremia patients were younger, had higher WBC, lower hemoglobin, albumin, and CO~2~CP, and had more severe liver injuries at admission than CA-hypernatremia patients. [Table 3](#t3-medscimonit-23-2408){ref-type="table"} shows that the patients with persistent hyponatremia were older, more were males, and more had higher aspartate aminotransferase (AST) and total bilirubin (TBIL) and lower WBC, SCr, serum sodium, and osmolality at admission than the patients with improved hyponatremia. Compared with the improved hypernatremia group, patients in the persistent hypernatremia group had higher serum sodium, chlorine, magnesium, calcium, phosphorus, and osmolality, and had lower AST at admission. Patients in the "hypo- to hyper-" mixed dysnatremia group were older, had higher WBC and K^+^, and had lower hemoglobin, albumin, SUA, Na^+^, Cl^−^, osmolality, and CO~2~CP at admission than the patients in the "hyper- to hypo-" group.

Prevalence of dysnatremia in various underlying diseases
--------------------------------------------------------

The prevalence of dysnatremia in different underlying diseases is shown in [Figure 2](#f2-medscimonit-23-2408){ref-type="fig"}, and detailed information is provided in [Tables 1](#t1-medscimonit-23-2408){ref-type="table"}[](#t2-medscimonit-23-2408){ref-type="table"}--[3](#t3-medscimonit-23-2408){ref-type="table"}. The top 4 underlying diseases of hyponatremia were cardiothoracic surgery (32.5%), cancer (31.3%), general surgery (18.8%), and pulmonary diseases (18.7%), while the top 4 ones of hypernatremia were neurological (5.6%), cardiothoracic surgery (4.6%), endocrine (2.4%), and urinary and renal diseases (2.1%). Mixed dysnatremia most often occured in patients with cardiothoracic surgery (1.5%) and neurological diseases (1.0%). The incidence rates of HA-hyponatremia and HA-hypernatremia were higher than the rates of corresponding CA-dysnatremia in patients with cardiothoracic surgery, general surgery, and cancer, while the rates were lower in patients with pulmonary, digestive, and cardiovascular diseases. There were fewer patients with HA-hyponatremia than CA-hyponatremia in endocrine, hematological, and urinary and renal diseases. Hyponatremia was more likely to be persistent than become improved in patients with digestive, pulmonary, gynecological, neurological, general surgery, and urinary and renal diseases, while hypernatremia was more likely to be persistent than become improved in patients with urinary and renal, orthopedic surgery, cardiovascular, hematological, pulmonary, and digestive diseases. All the above differences were statistically significant. "Hypo- to hyper-" mixed dysnatremia was more likely to occur in neurological and urinary and renal diseases than "hyper- to hypo-" mixed dysnatremia, and the reverse was true in cardiothoracic surgery.

Outcomes associated with dysnatremia
------------------------------------

The frequency of sodium levels at admission and its relation to hospital mortality are shown in [Figure 3](#f3-medscimonit-23-2408){ref-type="fig"}. The graph also shows the U-shaped relationship, the fitting curve, and equation. As demonstrated in [Figure 4](#f4-medscimonit-23-2408){ref-type="fig"} and [Supplementary Table 1](#s1-medscimonit-23-2408){ref-type="supplementary-material"}, hyponatremia, hypernatremia, and mixed dysnatremia increased hospital mortality, the incidence of AKI, the length of hospital stay, and hospital costs when compared with the normonatremia group. Also, hospital mortalities and AKI were higher, the length of hospital stay was longer, and hospital costs were higher in HA-dysnatremia groups than in the corresponding CA-dysnatremia groups, except that hospital mortality in the HA-hyponatremia group was lower than in the CA-hyponatremia group. Hospital mortalities and AKI were lower, the length of hospital stay was shorter, and hospital costs were lower in persistent dysnatremia groups than in the corresponding improved dysnatremia groups, except that hospital mortality in the persistent hypernatremia group was higher than in the improved hypernatremia group. In addition, the hospital mortality in the "hypo- to hyper-" mixed dysnatremia group was greater than in the "hyper- to hypo-" group (79.7% *vs.* 20.3%, respectively, *P*=0.000). All differences were statistically significant. Survival analysis ([Figure 5](#f5-medscimonit-23-2408){ref-type="fig"}) shows the differences in hospital survival.

Multiple logistic regression analyses of risk factors for hospital mortality
----------------------------------------------------------------------------

We further conducted multiple logistic regression analyses to identify dysnatremia and other independent risk factors for hospital mortality in 3 models, and the results are shown in [Tables 4](#t4-medscimonit-23-2408){ref-type="table"} and [5](#t5-medscimonit-23-2408){ref-type="table"}. In all 3 models, mixed dysnatremia was identified as the leading independent risk factor for hospital mortality (OR: 22.344 to 22.387, *P*=0.000). The results from Model 1 revealed that hypernatremia was a stronger predictor of hospital mortality than hyponatremia (OR \[95% CI\]: 13.387 \[10.642--16.840\] *vs.* 2.225 \[1.857--2.667\]). The OR of HA-hypernatremia for mortality was nearly twice that of CA-hypernatremia (OR \[95% CI\]: 16.216 \[12.588--20.888\] *vs.* 8.827 \[6.141--12.689\]), while the OR of HA-hyponatremia for mortality was slightly higher than that of CA-hyponatremia (OR \[95% CI\]: 16.216 \[12.588--20.888\] *vs.* 8.827 \[6.141--12.689\]). The OR of persistent hypernatremia for mortality was 3 times higher than that of improved hypernatremia (OR \[95% CI\]: 22.983 \[17.554--30.092\] *vs.* 6.830 \[4.903--9.516\]). However, the OR of persistent hyponatremia for mortality was lower than that of improved hyponatremia (OR \[95% CI\]: 2.023 \[1.653--2.476\] *vs.* 2.563 \[2.062--3.186\]). In addition, the OR of "hypo- to hyper-" mixed dysnatremia for mortality was higher than that of the "hyper- to hypo-" group (OR \[95% CI\]: 56.884 \[35.098--92.193\] *vs.* 6.629 \[3.499--12.557\]).

In addition to dysnatremia, 16 risk factors for hospital mortality were also identified, including older age, male sex, BMI \<18.5 kg/m^2^, DBP at admission \>90 mmHg, and laboratory variables at admission (hypochloremia, CO~2~CP \>29 mmol/L, AG \>16 mmol/L, increased ALT and TBIL, decreased albumin and hemoglobin, WBC\>12×10^9^/L, increased BUN, lower SCr, hypouricemia, and hyperuricemia).

Subgroup analyses
-----------------

To identify the high-risk patients with poor outcomes, we also conducted subgroup analyses of dysnatremia as risk factors for hospital mortality. [Supplementary Table 2](#s2-medscimonit-23-2408){ref-type="supplementary-material"} shows that age ≤65 years, BMI \<18.5 kg/m^2^, the incidence of AKI, and length of hospital stay ≤30 days increased the ORs of hypernatremia for mortality compared to other subgroups. Different ORs of dysnatremia for mortality were also observed across various underlying diseases. The top 3 ORs of hypernatremia were from cardiothoracic surgery (OR 27.029, 95% CI 12.388--58.976, *P*=0.000), urinary and renal (OR 17.257, 95% CI 8.551--34.826, *P*=0.000), and neurological diseases (OR 16.821, 95%CI 8.191--34.544, *P*=0.000). [Supplementary Table 3](#s3-medscimonit-23-2408){ref-type="supplementary-material"} shows that the ORs of HA-hypernatremia were higher in these patients with age ≤65 years, male sex, BMI \<18.5 kg/m^2^, AKI, and length of hospital stay ≤30 days than in other corresponding subgroups. The different ORs of CA- and HA-dysnatremia for mortality across various underlying diseases are also displayed, and both HA-hyponatremia and HA-hypernatremia increased the risk of death in patients with digestive diseases compared to other diseases according to the ORs (21.924 \[4.875--98.609\] *vs.* 55.185 \[13.645--223.184\], respectively). [Supplementary Table 4](#s4-medscimonit-23-2408){ref-type="supplementary-material"} shows that age ≤65 years, BMI \<18.5 kg/m^2^, presence of AKI, and length of hospital stay ≤30 days elevated the ORs of persistent hyponatremia for mortality compared to the corresponding subgroups. BMI \<18.5 kg/m^2^, and length of hospital stay ≤30 days also increased the ORs of persistent hypernatremia for mortality. The top 3 ORs of persistent hyponatremia were from hematological diseases, cancer, and cardiothoracic surgery (OR: 29.114, 11.343, and 10.885, respectively), while the top 3 ORs of persistent hypernatremia were from digestive, hematological, and urinary and renal diseases (OR: 50.959, 37.481, and 32.258, respectively).

Risk factors for developing HA-dysnatremia and persistent dysnatremia
---------------------------------------------------------------------

As before, if HA-dysnatremia is prevented and dysnatremia is corrected in a timely and appropriate manner, in-hospital mortality can be reduced significantly. Therefore, we further conducted multinomial logistic regression analysis. Patients with cancer, cardiothoracic surgery, general surgery, and neurological diseases were prone to develop both HA-hyponatremia and HA-hypernatremia, while patients with cardiovascular, hematological, and gynecological diseases and orthopedic surgery were more likely to develop HA-hyponatremia, and patients with endocrine diseases were high-risk patients for HA-hypernatremia. Hyponatremia was prone to continue until discharge or death in patients with cardiovascular surgery and pulmonary, digestive, and gynecological diseases. Other risk factors were also identified and are shown in [Supplementary Table 5](#s5-medscimonit-23-2408){ref-type="supplementary-material"}.

Discussion
==========

In this observational study, we found that dysnatremia was common in hospitalized patients and was independently associated with poor outcomes, including higher hospital mortality and incidence of AKI, longer length of hospital stay, and higher hospital costs than in patients with normonatremia. Nearly half of dysnatremia happened during hospitalization, while half of hypernatremia and one-third of hyponatremia continued until discharge or death. Multiple logistic regression revealed that all kinds of dysnatremia were independently associated with in-hospital mortality, and mixed dysnatremia (especially "hypo- to hyper-" ones), hypernatremia (especially HA- and persistent hypernatremia), were strong predictors of mortality. Further subgroup analyses proved that the effects of dysnatremia on in-hospital mortality were influenced by age, sex, BMI, AKI, length of hospital stay, and underlying diseases. Patients with cardiothoracic surgery, general surgery, cancer, and neurological diseases were more likely to develop HA-dysnatremia. Other independent risk factors for in-hospital mortality and predictors of HA- and persistent dysnatremia were also identified.

Hyponatremia is the most common electrolyte disorder encountered in clinical practice \[[@b19-medscimonit-23-2408]\]. The reported prevalence of hyponatremia is determined by various factors, including the definition of hyponatremia, the time of onset, the clinical setting, and the patient population. The incidence of hyponatremia has been reported to be 14.5% on initial measurement in hospitalized patients \[[@b20-medscimonit-23-2408]\]. Our study found that the total incidence of hyponatremia was 16.8% in hospitalized patients, 46.3% had hyponatremia at admission and 53.7% had it after 24 h of hospitalization, indicating that the incidence of HA-hyponatremia may be underestimated. Timely correction of hyponatremia may be another factor affecting outcomes. Therefore, hyponatremia patients were also divided into improved and persistent groups according to the serum sodium levels before discharge or at death. We found that 34.2% had improved hyponatremia, and 65.8% had persistent hyponatremia. A recent study based on the general population \[[@b21-medscimonit-23-2408]\] reported that hyponatremia was more common in patients with hypertension, diabetes, coronary artery disease, stroke, chronic obstructive pulmonary disease, and cancer, and was less common in those with none of these comorbidities. In our study, the top 4 underlying conditions associated hyponatremia were cardiothoracic surgery (32.5%), cancer (31.3%), general surgery (18.8%), and pulmonary diseases (18.7%), and the incidence of hyponatremia was 14.7% and 9.0% in cardiovascular and neurological diseases, respectively.

Hypernatremia is another common electrolyte disturbance and is always a reflection of water loss rather than sodium gain. However, it can also be associated with concomitant loss of sodium via hypotonic fluids or adding hypertonic fluids. Research in 2 large Dutch cohorts \[[@b22-medscimonit-23-2408]\] reported a marked shift in the incidence of dysnatremia from hyponatremia to hypernatremia over 2 decades in ICU patients, which may be related to the increased use of sodium-containing infusions, diuretics, and hydrocortisone. Therefore, iatrogenic factors play a major role in the occurrence and development of hypernatremia. In critically ill patients, the incidence of hypernatremia at admission was 6.9% \[[@b2-medscimonit-23-2408]\], and 7.7% of the patients with normonatremia at admission developed hypernatremia during ICU hospitalization \[[@b23-medscimonit-23-2408]\]. Our study found that the total incidence of hypernatremia was 1.9% in hospitalized patients: 50.4% developed hypernatremia at admission and 49.6% after 24 h of hospitalization; 50.9% had improved hypernatremia; and 49.1% had persistent hypernatremia. The top 4 underlying conditions associated with hypernatremia were neurological diseases (5.6%), cardiothoracic surgery (4.6%), endocrine diseases (2.4%), and urinary and renal diseases (2.1%).

Extensive studies have proved the association between dysnatremia and poor outcomes. In this study, we further showed that hypernatremia (OR 13.387, 95% CI 10.642--16.840, P=0.000) and mixed dysnatremia (OR 22.344, 95% CI 15.709--31.783, *P*=0.000) were stronger predictors of mortality than was hyponatremia (OR 2.225, 95% CI 1.857--2.667, *P*=0.000). Improper correction of dysnatremia can lead to mixed dysnatremia. One survey \[[@b16-medscimonit-23-2408]\] proved that fluctuations in serum sodium levels were independently associated with an increased risk of in-hospital mortality. The mortality rate of patients with mixed dysnatremia in ICU may be up to 42% \[[@b15-medscimonit-23-2408]\], and we reported that the mortality was 24.2% in hospitalized patients. The OR of mortality was elevated if hyponatremia was over-corrected and changed to hypernatremia (OR 56.884, 95% CI 35.098--92.193, *P*=0.000). However, not only a too quick, but also a too slow correction can increase the risk of death regardless of initial dysnatremia \[[@b24-medscimonit-23-2408]\]. The ORs of HA- and persistent hypernatremia for in-hospital mortality were obviously higher than the ORs of CA- and improved hypernatremia. These differences of ORs did not exist in hyponatremia. All data indicated that hypernatremia was a strong predictor of in-hospital death, and needed to be corrected in a timely and appropriate manner, while hyponatremia required careful correction.

The effect of dysnatremia on in-hospital mortality may vary substantially across different clinical settings and patient population. Therefore, we further tried to identify the patients at high risk of in-hospital death when dysnatremia occurs. Limited studies have reported the risk factors that increase the ORs of dysnatremia for mortality. Several risk factors were identified in our study. Although older age (\>65 years) increased the risk of death in patients with persistent hypernatremia and mixed dysnatremia, the risk of mortality in younger patients was higher in other kinds of dysnatremia than in older patients. This difference have occurred because dysnatremia developed in younger patients only when the underlying diseases were more severe. Low BMI (\<18.5 kg/m^2^) also increased the risk of mortality in patients with HA-hypernatremia, improved and persistent hypernatremia, mixed dysnatremia, and persistent hyponatremia compared to normal and high BMI patients.

Since dysnatremia was independently associated with poor outcomes, we can improve the prognosis of these patients if HA-dysnatremia is prevented and dysnatremia is corrected in a timely and appropriate manner. The main finding in this respect was that there are different risks of dysnatremia in various underlying diseases. Patients with cancer, cardiothoracic surgery, general surgery, and neurological diseases were prone to develop both HA-hyponatremia and HA-hypernatremia. Age, sex, and BMI had not only a great impact on the risk of death, but also on the incidence of dysnatremia. We also identified several risk factors from laboratory data at admission for HA-dysnatremia and persistent dysnatremia.

The present study has several limitations. First, it was designed as an observational and retrospective study and was open to selection bias. Second, we defined persistent dysnatremia when dysnatremia continued until discharge or death, and if not, improved dysnatremia was defined, which had not been reported and needed further evaluation. Although we tried to include many clinical risk factors, some relevant data, including fluid administration, were unavailable in this study.

Conclusions
===========

Dysnatremia was independently associated with poor outcomes. Hospital-acquired and persistent hypernatremia were strong risk factors for in-hospital mortality. Effective prevention and proper correction of dysnatremia in high-risk patients may reduce the in-hospital mortality, but hyponatremia should be carefully corrected.

Supplementary Tables
====================

###### 

Outcomes of included patients with dysnatremia.

  Group                                AKI, n (%)     Death, n (%)   Length of hospital stay, days                                            Hospital cost, RMB
  ------------------------------------ -------------- -------------- ------------------------------------------------------------------------ --------------------------------------------------------------------------------------
  **Model 1**                                                                                                                                 
   Normonatremia                       6,149 (8.3)    317 (0.4)      5.0 (2.5--8.0)                                                           13,869.1 (7,669.2--32,798.7)
   Hyponatremia                        4,446 (29.2)   439 (2.9)      10.0 (5.5--15.0)[\#](#tfn14-medscimonit-23-2408){ref-type="table-fn"}    29,533.5 (13,362.4--60,616.8)[\#](#tfn14-medscimonit-23-2408){ref-type="table-fn"}
   Hypernatremia                       764 (45.3)     204 (12.1)     10.5 (6.0--17.0)[\#](#tfn14-medscimonit-23-2408){ref-type="table-fn"}    37,104.3 (14,016.3--80,466.7)[\#](#tfn14-medscimonit-23-2408){ref-type="table-fn"}
   Mixed dysnatremia                   233 (81.8)     69 (24.2)      21.0 (13.5--32.5)[\#](#tfn14-medscimonit-23-2408){ref-type="table-fn"}   106,510.3 (46,623.5--180,214.8)[\#](#tfn14-medscimonit-23-2408){ref-type="table-fn"}
   *P* value (χ^2^ or ANOVA)           0.000          0.000          0.000                                                                    0.000
  **Model 2**                                                                                                                                 
   CA-hyponatremia                     1,677 (23.8)   291 (4.1)      7.0 (4.0--12.5)                                                          16,176.1 (9,060.1--33,854.8)
   HA-hyponatremia                     2,769 (33.9)   148 (1.8)      11.5 (8.0--16.5)                                                         46,061.3 (23,207.6--83,343.8)
   *P* value                           0.000          0.000          0.000                                                                    0.000
   CA-hypernatremia                    247 (29.1)     83 (9.8)       7.0 (3.5--12.5)                                                          20,248.1 (9,198.2--46,825.4)
   HA-hypernatremia                    517 (61.8)     121 (14.5)     14.0 (9.5--21.5)                                                         60,351.1 (29,892.6--121,096.3)
   *P* value                           0.000          0.003          0.000                                                                    0.000
  **Model 3**                                                                                                                                 
   Improved hyponatremia               1,888 (36.2)   176 (3.4)      12.5 (8.5--18.5)                                                         41,283.8 (20,389.7--71,168.3)
   Persistent hyponatremia             2,558 (25.5)   263 (2.6)      8.0 (4.5--13.5)                                                          22,206.9 (11,558.2--54,202.7)
   *P* value                           0.000          0.008          0.000                                                                    0.000
   Improved hypernatremia              488 (56.8)     61 (7.1)       14.0 (9.5--21.0)                                                         57,157.7 (30,575.9--116,872.8)
   Persistent hypernatremia            276 (33.3)     143 (17.3)     7.0 (3.5--12.0)                                                          17,773.6 (8,782.9--49,237.5)
   *P* value                           0.000          0.000          0.000                                                                    0.000
   "Hypo to hyper" mixed dysnatremia   82 (35.2)      55 (79.7)      21.8 (13.4--38.5)                                                        89,939.4 (29,995.7--180,373.3)
   "Hyper to hypo" mixed dysnatremia   151 (64.8)     14 (20.3)      20.5 (14.0--30.5)                                                        113,523 (52,375.1--181,003.8)
   *P* value                           0.657          0.000          0.603                                                                    0.050

*P*\<0.001 *vs.* normonatremia group.

AKI -- acute kidney injury; RMB -- Ren Min Bi; CA -- community-acquired; HA -- hospital-acquired.

###### 

Subgroup multiple logistic regression analysis of dysnatremia as independent risk factors for hospital mortality in model 1.

  Subgroup                           Hyponatremia[§](#tfn16-medscimonit-23-2408){ref-type="table-fn"}   Hypernatremia[§](#tfn16-medscimonit-23-2408){ref-type="table-fn"}   Mixed dysnatremia[§](#tfn16-medscimonit-23-2408){ref-type="table-fn"}                                          
  ---------------------------------- ------------------------------------------------------------------ ------------------------------------------------------------------- ----------------------------------------------------------------------- ------- ------------------------------ -------
  **Age, year**                                                                                                                                                                                                                                                                            
   ≤65                               2.722 (2.034--3.643)                                               0.000                                                               18.350 (12.853--26.198)                                                 0.000   21.886 (11.753--40.755)        0.000
   \<65                              2.075 (1.653--2.606)                                               0.000                                                               11.112 (8.440--14.631)                                                  0.000   24.623 (16.162--37.513)        0.000
  **Gender**                                                                                                                                                                                                                                                                               
   Male                              1.963 (1.575--2.447)                                               0.000                                                               14.659 (11.014--19.512)                                                 0.000   21.475 (13.748--33.544)        0.000
   Female                            2.860 (2.090--3.913)                                               0.000                                                               11.952 (8.231--17.353)                                                  0.000   27.276 (15.320--48.564)        0.000
  **BMI, kg/m^2^**                                                                                                                                                                                                                                                                         
   \<18.5                            1.534 (0.453--5.198)                                               0.492                                                               71.139 (12.345--409.950)                                                0.000   1233.153 (38.420--39580.284)   0.000
   18.5--24.99                       2.297 (1.906--2.769)                                               0.000                                                               13.003 (10.241--16.509)                                                 0.000   20.950 (14.578--30.105)        0.000
   ≥25                               1.689 (0.632--4.513)                                               0.296                                                               7.195 (2.006--25.806)                                                   0.002   32.104 (2.952--349.133)        0.004
  **Underlying diseases**                                                                                                                                                                                                                                                                  
   Cancer                            1.635 (1.069--2.502)                                               0.023                                                               11.942 (6.105--23.359)                                                  0.000   26.998 (9.615--75.806)         0.000
   Pulmonary                         3.062 (2.010--4.633)                                               0.000                                                               6.266 (3.353--11.710)                                                   0.000   25.139 (7.850--80.503)         0.000
   Cardiovascular                    4.863 (3.203--7.385)                                               0.000                                                               9.117 (5.037--16.502)                                                   0.000   9.550 (2.855--31.946)          0.000
   Digestive                         1.445 (0.726--2.877)                                               0.295                                                               11.231 (3.914--32.232)                                                  0.000   53.383 (13.800--206.493)       0.000
   Hematological                     3.398 (2.103--5.490)                                               0.000                                                               8.980 (3.723--21.660)                                                   0.000   48.642 (8.840--267.664)        0.000
   Neurological                      2.199 (1.038--4.658)                                               0.040                                                               16.821 (8.191--34.544)                                                  0.000   23.310 (7.966--68.207)         0.000
   Urinary and renal                 1.390 (0.746--2.588)                                               0.300                                                               17.257 (8.551--34.826)                                                  0.000   33.917 (7.819--147.114)        0.000
   Cardiothoracic surgery            2.385 (1.065--5.340)                                               0.035                                                               27.029 (12.388--58.976)                                                 0.000   18.501 (6.336--54.021)         0.000
   General surgery                   2.282 (1.056--4.931)                                               0.036                                                               6.568 (2.299--18.763)                                                   0.000   8.285 (1.500--45.761)          0.003
   Others                            2.321 (10.22--5.273)                                               0.044                                                               11.917 (4.531--31.341)                                                  0.000   77.078 (16.156--367.723)       0.000
  **AKI**                                                                                                                                                                                                                                                                                  
   Yes                               1.810 (1.411--2.322)                                               0.000                                                               10.784 (8.161--14.252)                                                  0.000   11.053 (7.502--16.285)         0.000
   No                                1.526 (1.157--2.013)                                               0.003                                                               4.596 (2.817--7.499)                                                    0.000   16.996 (6.574--43.944)         0.000
  **Length of hospital stay, day**                                                                                                                                                                                                                                                         
   ≤30                               1.627 (1.323--2.001)                                               0.000                                                               14.168 (11.042--18.179)                                                 0.000   18.563 (11.980--28.763)        0.000
   \>30                              2.928 (1.879--4.561)                                               0.000                                                               5.233 (2.926--9.360)                                                    0.000   9.789 (5.116--18.730)          0.000

Normonatremia as the reference.

BMI -- body mass index; AKI -- acute kidney injury; OR -- odds ratio; CI -- confidence interval.

###### 

Subgroup multiple logistic regression analysis of dysnatremia as independent risk factors for hospital mortality in model 2.

  Subgroup                           CA-hyponatremia[§](#tfn18-medscimonit-23-2408){ref-type="table-fn"}   HA-hyponatremia[§](#tfn18-medscimonit-23-2408){ref-type="table-fn"}   CA-hypernatremia[§](#tfn18-medscimonit-23-2408){ref-type="table-fn"}   HA-hypernatremia[§](#tfn18-medscimonit-23-2408){ref-type="table-fn"}   Mixed dysnatremia[§](#tfn18-medscimonit-23-2408){ref-type="table-fn"}                                                                             
  ---------------------------------- --------------------------------------------------------------------- --------------------------------------------------------------------- ---------------------------------------------------------------------- ---------------------------------------------------------------------- ----------------------------------------------------------------------- ------- -------------------------- ------- ------------------------------ -------
  **Age, year**                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
   ≤65                               2.433 (1.694--3.495)                                                  0.000                                                                 3.077 (2.216--4.273)                                                   0.000                                                                  9.953 (5.545--17.865)                                                   0.000   22.295 (14.862--33.445)    0.000   18.570 (9.827--35.092)         0.000
   \>65                              1.878 (1.414--2.494)                                                  0.000                                                                 2.329 (1.786--3.037)                                                   0.000                                                                  7.767 (5.146--11.724)                                                   0.000   13.665 (9.957--18.754)     0.000   23.599 (15.462--36.017)        0.000
  **Gender**                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
   Male                              1.755 (1.335--2.308)                                                  0.000                                                                 2.219 (1.713--2.875)                                                   0.000                                                                  9.094 (5.740--14.406)                                                   0.000   18.348 (13.365--25.190)    0.000   20.081 (12.820--31.454)        0.000
   Female                            2.307 (1.561--3.410)                                                  0.000                                                                 3.387 (2.389--4.803)                                                   0.000                                                                  8.502 (4.900--14.752)                                                   0.000   13.847 (9.030--21.232)     0.000   25.346 (14.148--45.406)        0.000
  **BMI, kg/m^2^**                                                                                                                                                                                                                                                                                                                                                                                                                                                               
   \<18.5                            2.063 (0.531--8.018)                                                  0.296                                                                 0.961 (0.168--5.515)                                                   0.965                                                                  --                                                                      --      74.385 (12.840--430.910)   0.000   1112.828 (35.443--34940.099)   0.000
   18.5--24.99                       1.951 (1.543--2.4680)                                                 0.000                                                                 2.696 (2.182--3.332)                                                   0.000                                                                  8.762 (6.066--12.655)                                                   0.000   15.957 (12.260--20769)     0.000   19.960 (13.854--28.758)        0.000
   ≥25                               3.595 (1.223--10.570)                                                 0.020                                                                 0.455 (0.058--3.565)                                                   0.454                                                                  9.688 (1.099--85.409)                                                   0.041   7.266 (1.712--30.840)      0.007   34.163 (3.095--377.072)        0.004
  **Underlying diseases**                                                                                                                                                                                                                                                                                                                                                                                                                                                        
   Cancer                            1.368 (0.804--2.328)                                                  0.248                                                                 0.036 (0.001--1.2)                                                     0.063                                                                  19.477 (9.896--38.334)                                                  0.000   33.15 (12.192--90.129)     0.000   1.368 (0.804--2.328)           0.248
   Pulmonary                         2.886 (1.546--5.389)                                                  0.001                                                                 3.527 (1.571--7.919)                                                   0.002                                                                  11.744 (5.31--25.971)                                                   0.000   24.852 (7.745--79.748)     0.000   2.886 (1.546--5.389)           0.001
   Cardiovascular                    4.514 (2.7--7.548)                                                    0.000                                                                 6.997 (3.207--15.263)                                                  0.000                                                                  12.403 (5.67--27.133)                                                   0.000   9.718 (2.904--32.513)      0.000   4.514 (2.7--7.548)             0.000
   Digestive                         1.991 (0.855--4.635)                                                  0.110                                                                 21.924 (4.875--98.609)                                                 0.000                                                                  7.671 (1.914--30.755)                                                   0.004   55.185 (13.645--223.184)   0.000   1.991 (0.855--4.635)           0.110
   Hematological                     3.627 (1.909--6.89)                                                   0.000                                                                 4.458 (1.212--16.404)                                                  0.025                                                                  17.19 (4.915--60.119)                                                   0.000   28.916 (5.208--160.535)    0.000   3.627 (1.909--6.89)            0.000
   Neurological                      2.671 (1.112--6.42)                                                   0.028                                                                 8.124 (2.671--24.713)                                                  0.000                                                                  24.574 (11.16--54.11)                                                   0.000   23.028 (7.879--67.307)     0.000   2.671 (1.112--6.42)            0.028
   Urinary and renal                 2.579 (1.175--5.661)                                                  0.018                                                                 13.427 (4.347--41.475)                                                 0.000                                                                  20.734 (9.183--46.811)                                                  0.000   36.159 (7.867--166.184)    0.000   2.579 (1.175--5.661)           0.018
   Cardiothoracic surgery            2.09 (0.875--4.994)                                                   0.097                                                                 20.563 (6.3--67.125)                                                   0.000                                                                  29.047 (12.987--64.968)                                                 0.000   18.291 (6.262--53.425)     0.000   2.09 (0.875--4.994)            0.097
   General surgery                   2.559 (1.084--6.039)                                                  0.032                                                                 5.917 (1.332--26.276)                                                  0.019                                                                  5.545 (1.547--19.872)                                                   0.009   6.703 (1.179--38.101)      0.032   2.559 (1.084--6.039)           0.032
   Others                            3.039 (1.109--8.327)                                                  0.031                                                                 11.19 (2.581--48.514)                                                  0.001                                                                  12.402 (3.918--39.254)                                                  0.000   71.597 (14.877--344.574)   0.000   3.039 (1.109--8.327)           0.031
  **AKI**                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
   Yes                               1.666 (1.224--2.266)                                                  0.001                                                                 1.921 (1.455--2.537)                                                   0.000                                                                  10.749 (7.000--16.507)                                                  0.000   10.869 (8.026--14.720)     0.000   10.983 (7.443--16.206)         0.000
   No                                1.558 (1.110--2.188)                                                  0.010                                                                 1.541 (1.080--2.199)                                                   0.017                                                                  2.844 (1.391--5.817)                                                    0.004   7.200 (3.939--13.163)      0.000   17.113 (6.638--44.117)         0.000
  **Length of hospital stay, day**                                                                                                                                                                                                                                                                                                                                                                                                                                               
   ≤30                               1.599 (1.241--2.061)                                                  0.000                                                                 1.781 (1.381--2.296)                                                   0.000                                                                  8.593 (5.808--12.712)                                                   0.000   17.738 (13.487--23.329)    0.000   17.934 (11.561--27.822)        0.000
   \>30                              4.548 (2.809--7.363)                                                  0.000                                                                 2.718 (1.701--4.342)                                                   0.000                                                                  5.579 (2.488--12.509)                                                   0.000   4.680 (2.461--8.902)       0.000   10866 (5.760--20.499)          0.000

Normonatremia as the reference.

CA -- community-acquired; HA -- hospital-acquired; BMI -- body mass index; AKI -- acute kidney injury; OR -- odds ratio; CI -- confidence interval.

###### 

Subgroup multiple logistic regression analysis of dysnatremia as independent risk factors for hospital mortality in model 3.

  Subgroup                           Improved hyponatremia   Persistent hyponatremia   Improved hypernatremia    Persistent hypernatremia                                                                   
  ---------------------------------- ----------------------- ------------------------- ------------------------- -------------------------- ------------------------- ------- ----------------------------- -------
  **Age, year**                                                                                                                                                                                             
   ≤65                               2.887 (2.113--3.945)    0.000                     12.639 (7.705--20.731)    0.000                      25.364 (16.541--38.893)   0.000   21.923 11.773--40.825)        0.000
   \>65                              1.644 (1.264--2.138)    0.000                     4.827 (3.166--7.359)      0.000                      20.010 (14.552--27.516)   0.000   24.275 (15.899--37.066)       0.000
  **Gender**                                                                                                                                                                                                
   Male                              1.779 (1.394--2.271)    0.000                     7.318 (4.819--11.113)     0.000                      26.151 (18.611--36.745)   0.000   21.742 (13.914--33.974)       0.000
   Female                            2.555 (1.794--3.639)    0.000                     6.448 (3.781--10.996)     0.000                      19.409 (12.602--29.891)   0.000   27.078 (15.178--48.307)       0.000
  **BMI, kg/m^2^**                                                                                                                                                                                          
   \<18.5                            1.931 (0.472--7.894)    0.360                     20.986 (14.599--30.168)   0.000                      55.895 (8.888--351.535)   0.000   1209.328 (37.744--38746.89)   0.000
   18.5--24.99                       2.093 (1.701--2.576)    0.000                     6.28 (4.43--8.902)        0.000                      22.766 (17.252--30.042)   0.000   20.986 (14.599--30.168)       0.000
   ≥25                               1.777 (0.559--5.648)    0.330                     5.025 (0.587--42.991)     0.140                      8.816 (1.948--39.891)     0.005   32.095 (2.959--348.159)       0.004
  **Underlying diseases**                                                                                                                                                                                   
   Cancer                            1.184 (0.731--1.916)    0.492                     11.343 (5.09--25.277)     0.000                      13.494 (4.684--38.876)    0.000   25.983 (9.194--73.434)        0.000
   Pulmonary                         3.416 (2.139--5.456)    0.000                     0.962 (0.288--3.214)      0.949                      16.5 (8.103--33.597)      0.000   25.592 (7.866--83.263)        0.000
   Cardiovascular                    4.409 (2.724--7.137)    0.000                     5.893 (2.519--13.789)     0.000                      13.128 (6.396--26.943)    0.000   9.585 (2.866--32.059)         0.000
   Digestive                         1.44 (0.699--2.963)     0.323                     3.019 (0.329--27.677)     0.328                      16.053 (5.374--47.952)    0.000   50.959 (13.174--197.116)      0.000
   Hematological                     2.78 (1.571--4.918)     0.000                     29.114 (7.417--114.275)   0.000                      3.738 (1.076--12.978)     0.038   37.481 (7.029--199.851)       0.000
   Neurological                      1.492 (0.598--3.722)    0.391                     8.002 (3.076--20.817)     0.000                      47.75 (20.678--110.263)   0.000   28.754 (9.403--87.927)        0.000
   Urinary and renal                 1.67 (0.829--3.364)     0.152                     4.526 (0.977--20.973)     0.054                      24.442 (11.571--51.631)   0.000   32.258 (7.501--138.731)       0.000
   Cardiothoracic surgery            0.936 (0.304--2.882)    0.909                     10.885 (4.104--28.867)    0.000                      79.21 (32.91--190.65)     0.000   18.084 (6.162--53.07)         0.000
   General surgery                   2.279 (0.966--5.377)    0.060                     3.499 (0.86--14.233)      0.080                      15.866 (4.211--59.776)    0.000   8.242 (1.487--45.693)         0.016
   Others                            3.978 (1.902--8.317)    0.000                     2.31 (0.425--12.545)      0.332                      29.003 (10.267--81.93)    0.000   122.536 (27.544--545.138)     0.000
  **AKI**                                                                                                                                                                                                   
   Yes                               1.915 (1.457--2.518)    0.000                     4.893 (3.387--7.068)      0.000                      25.307 (18.021--35.538)   0.000   10.927 (7.422--16.087)        0.000
   No                                1.247 (0.911--1.706)    0.168                     1.656 (0.591--4.643)      0.337                      7.438 (4.331--12.774)     0.000   17.028 (6.573--44.108)        0.000
  **Length of hospital stay, day**                                                                                                                                                                          
   ≤30                               1.507 (1.197--1.898)    0.000                     7.109 (4.89--10.337)      0.000                      22.685 (16.984--30.299)   0.000   18.657 (12.039--28.914)       0.000
   \>30                              3.514 (2.166--5.703)    0.000                     2.823 (1.411--5.651)      0.003                      25.407 (10.435--61.859)   0.000   9.913 (5.18--18.973)          0.000

Normonatremia as the reference.

BMI -- body mass index; AKI -- acute kidney injury; OR -- odds ratio; CI -- confidence interval.

###### 

Multinomial logistic regression analysis of independent risk factors for developing of hospital-acquired and persistent dysnatremia.

  Variable                                                                       HA-hyponatremia           HA-hypernatremia   Persistent hyponatremia   Persistent hypernatremia                                                         
  ------------------------------------------------------------------------------ ------------------------- ------------------ ------------------------- -------------------------- ---------------------- ------- ---------------------- -------
  Age, per year increase                                                         1.008 (1.006--1.010)      0.000              1.019 (1.013--1.024)      0.000                      1.004 (1.002--1.006)   0.001                          
  Male sex                                                                       1.182 (1.117--1.252)      0.000              0.692 (0.596--0.804)      0.000                      1.258 (1.164--1.360)   0.000   1.274 (1.023--1.586)   0.030
  BMI \<18.5 kg/m^2^[§](#tfn23-medscimonit-23-2408){ref-type="table-fn"}         1.811 (1.396--2.350)      0.000                                                                                                                         
  BMI 25--27.99 kg/m^2^[§](#tfn23-medscimonit-23-2408){ref-type="table-fn"}      1.297 (1.102--1.527)      0.002                                                                                                                         
  BMI 28--32 kg/m^2^[§](#tfn23-medscimonit-23-2408){ref-type="table-fn"}         1.269 (0.959--1.680)      0.096                                                                                                                         
  Cancer                                                                         8.344 (7.640--9.113)      0.000              2.768 (2.173--3.525)      0.000                                                                            
  Pulmonary                                                                                                                                                                        1.449 (1.249--1.681)   0.000                          
  Cardiovascular                                                                 1.279 (1.145--1.428)      0.000                                                                                                                         
  Cardiothoracic surgery                                                         13.330 (12.125--14.654)   0.000              10.989 (9.009--13.403)    0.000                      1.416 (1.270--1.580)   0.000                          
  Digestive                                                                                                                                                                        1.651 (1.432--1.903)   0.000                          
  Endocrine                                                                                                                   2.187 (1.465--3.263)      0.000                                                                            
  General surgery                                                                4.042 (3.670--4.452)      0.000              1.843 (1.429--2.376)      0.000                                                                            
  Hematological                                                                  1.532 (1.280--1.834)      0.000                                                                                                                         
  Neurological                                                                   2.575 (2.185--3.035)      0.000              6.007 (4.586--7.868)      0.000                                                                            
  Gynecology                                                                     3.084 (2.565--3.708)      0.000                                                                   1.741 (1.330--2.279)   0.000                          
  Orthopedic surgery                                                             1.360 (1.128--1.640)      0.001                                                                                                                         
  SBP\>140 mmHg                                                                                                               1.359 (1.111--1.661)      0.003                                                                            
  DBP \<60 mmHg[§](#tfn23-medscimonit-23-2408){ref-type="table-fn"}              1.546 (1.304--1.834)      0.000              2.330 (1.657--3.276)      0.000                                                                            
  Glucose 5.7--10 mmol/L[§](#tfn23-medscimonit-23-2408){ref-type="table-fn"}     1.133 (1.071--1.198)      0.000                                                                                                                         
  Glucose \>10 mmol/L[§](#tfn23-medscimonit-23-2408){ref-type="table-fn"}        1.319 (1.163--1.496)      0.000                                                                                                                         
  Hypokalemia                                                                                                                 2.169 (1.769--2.659)      0.000                                                                            
  Hypochloremia[§](#tfn23-medscimonit-23-2408){ref-type="table-fn"}              2.064 (1.874--2.273)      0.000                                                                   1.420 (1.308--1.540)   0.000                          
  Hyperchloremia                                                                                                              1.868 (1.234--2.826)      0.003                                                                            
  Hypocalcemia                                                                   1.460 (1.344--1.586)      0.000              1.650 (1.347--2.021)      0.000                                                                            
  Hypomagnesemia                                                                 1.917 (1.492--2.464)      0.000              1.929 (1.107--3.362)      0.020                                                     1.579 (1.124--2.217)   0.008
  Hypermagnesemia                                                                                                             1.504 (1.174--1.928)      0.001                                                                            
  Hypophosphatemia                                                               1.142 (1.052--1.240)      0.002              1.818 (1.484--2.228)      0.000                                                                            
  Hyperphosphatemia                                                              1.242 (1.137--1.357)      0.000                                                                                                                         
  CO2CP \<23 mmol/L[§](#tfn23-medscimonit-23-2408){ref-type="table-fn"}          1.230 (1.155--1.310)      0.000                                                                                                                         
  AG \>16 mmol/L[§](#tfn23-medscimonit-23-2408){ref-type="table-fn"}             1.293 (1.199--1.394)      0.000              1.558 (1.298--1.870)      0.000                                                     1.370 (1.069--1.755)   0.013
  ALT, per 50 U/L increase                                                       1.015 (1.001--1.030)      0.041                                                                                                                         
  TBIL, per 20 μmol/L increase                                                   1.087 (1.066--1.108)      0.000              1.102 (1.059--1.147)      0.000                      1.031 (1.013--1.050)   0.001                          
  Albumin, per 5g/L decrease                                                     1.275 (1.234--1.318)      0.000              1.458 (1.347--1.578)      0.000                                                                            
  Hemoglobin (90--119 g/L)[§](#tfn23-medscimonit-23-2408){ref-type="table-fn"}   1.161 (1.090--1.237)      0.000                                                                   1.179 (1.087--1.280)   0.000                          
  Hemoglobin (60--89 g/L)[§](#tfn23-medscimonit-23-2408){ref-type="table-fn"}    1.471 (1.307--1.656)      0.000                                                                   1.277 (1.119--1.457)   0.000                          
  Hemoglobin (\<60 g/L)[§](#tfn23-medscimonit-23-2408){ref-type="table-fn"}      1.713 (1.303--2.252)      0.000                                                                   1.233 (0.929--1.638)   0.147                          
  WBC \<4.0×10^9^/L[§](#tfn23-medscimonit-23-2408){ref-type="table-fn"}                                                                                                            1.142 (1.025--1.273)   0.016                          
  WBC \>12.0×10^9^/L[§](#tfn23-medscimonit-23-2408){ref-type="table-fn"}         1.556 (1.378--1.758)      0.000              2.322 (1.805--2.987)      0.000                                                                            
  BUN, per 10 mg/dl increase                                                     1.107 (1.066--1.149)      0.000              1.238 (1.149--1.334)      0.000                                                                            
  SCr, per 0.5 mg/dl increase                                                                                                 0.958 (0.926--0.990)      0.011                                                                            
  Hypouricemia[§](#tfn23-medscimonit-23-2408){ref-type="table-fn"}               1.084 (1.003--1.170)      0.041                                                                                                                         
  Hyperuricemia[§](#tfn23-medscimonit-23-2408){ref-type="table-fn"}              1.135 (1.046--1.231)      0.002              1.481 (1.212--1.810)      0.000                      1.132 (1.012--1.267)   0.031                          

Normonatremia served as the reference for HA-dysnatremia and improved dysnatremia as the reference for corresponding persistent dysnatremia. For underlying diseases, the rest of the other patients served as the references.

Normal range as the reference.

BMI -- body mass index; SBP -- systolic blood pressure; DBP -- diastolic blood pressure; CO~2~CP -- carbon dioxide combining power; AG -- anion gap; ALT -- alanine aminotransferase; TBIL -- total bilirubin; WBC -- white blood cell; BUN -- blood urea nitrogen; SCr -- serum creatinine; OR -- odds ratio; CI -- confidence interval.
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![Flowchart of the study.\
CA -- community-acquired;\
HA -- hospital-acquired.](medscimonit-23-2408-g001){#f1-medscimonit-23-2408}

![Incidence or percentage of dysnatremia in various underlying diseases. (**A**) The incidence of hyponatremia, hypernatremia, and mixed dysnatremia; (**B**) Percentage of community-acquired or hospital-acquired dysnatremia; (**C**) Percentage of improved or persistent dysnatremia. CA -- community-acquired; HA -- hospital-acquired; HON -- hyponatremia; HEN -- hypernatremia.](medscimonit-23-2408-g002){#f2-medscimonit-23-2408}

![The histogram of the serum sodium levels at admission and its relation to hospital mortality. (**A**) The histogram of serum sodium levels at admission; (**B**) Non-linear relationship between baseline serum sodium levels and the predicted probability of hospital mortality. The range area indicates 95% confidence intervals.](medscimonit-23-2408-g003){#f3-medscimonit-23-2408}

![Outcomes of hospitalized patients with dysnatremia. (**A--C**) The incidence of acute kidney injury and hospital mortality; (**D--F**) The length of hospital stay and hospital cost. AKI -- acute kidney injury; CA -- community-acquired; HA -- hospital-acquired; HON -- hyponatremia; HEN -- hypernatremia; RMB -- Ren Min Bi. ^\#^ *P*\<0.01 compared with normonatremia (**D**), CA-dysnatremia (**B, E**) or improved dysnatremia (**C, F**).](medscimonit-23-2408-g004){#f4-medscimonit-23-2408}

![Kaplan-Meier survival curves stratified by dysnatremia categories. (**A**) Survival curve of hyponatremia, normonatremia, hypernatremia and mixed dysnatremia; (**B**) Survival curve of community-acquired *vs.* hospital-acquired dysnatremia; (**C**) Survival curve of improved *vs.* persistent dysnatremia, "hypo to hyper" *vs.* "hyper to hypo" mixed dysnatremia. The vertical lines represent censored subjects. The follow-up duration is different for each subject because it is censored at the end of hospitalization. CA -- community-acquired; HA -- hospital-acquired.](medscimonit-23-2408-g005){#f5-medscimonit-23-2408}

###### 

Baseline characteristics of patients according to dysnatremia during hospitalization.

  Variable                                                                            All (n=90,889)         Normonatremia (n=73,678)   Hyponatremia (n=15,239)                                                    Hypernatremia (n=1,687)                                                    Mixed dysnatremia (n=285)                                                  *P* value
  ----------------------------------------------------------------------------------- ---------------------- -------------------------- -------------------------------------------------------------------------- -------------------------------------------------------------------------- -------------------------------------------------------------------------- -----------
  **Age, year**                                                                       59.0 (49.0--67.0)      59.0 (48.0--67.0)          61.0 (51.0--70.0)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}      64.0 (54.0--74.0)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}      66.0 (56.0--74.0)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}      0.000
  **\>65, n (%)**                                                                     27,680 (30.5)          21,135 (28.7)              5,649 (37.1)                                                               751 (44.5)                                                                 145 (50.9)                                                                 0.000
  **Male sex, n (%)**                                                                 55,383 (60.9)          43,966 (59.7)              10,267 (67.4)                                                              968 (57.4)                                                                 182 (63.9)                                                                 0.000
  **BMI, kg/m^2^**                                                                    23.2 (20.8--25.6)      23.4 (21.0--25.7)          22.7 (20.5--25.1)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}      23.6 (21.4--25.9)                                                          22.5 (20.7--25.5)                                                          0.000
  **Underlying diseases, n (%)**[§](#tfn4-medscimonit-23-2408){ref-type="table-fn"}                                                                                                                                                                                                                                                                                      0.000
   Cancer                                                                             13,324 (100.0)         8,926 (67.0)               4,177 (31.3)                                                               188 (1.4)                                                                  33 (0.2)                                                                   
   Pulmonary                                                                          6,164 (100.0)          4,890 (79.3)               1,151 (18.7)                                                               108 (1.8)                                                                  15 (0.2)                                                                   
   Cardiovascular                                                                     16,139 (100.0)         14,427 (89.4)              1,445 (9.0)                                                                245 (1.5)                                                                  22 (0.1)                                                                   
   Digestive                                                                          10,091 (100.0)         8,614 (85.4)               1,363 (13.5)                                                               100 (1.0)                                                                  14 (0.1)                                                                   
   Endocrine                                                                          2,707 (100.0)          2,426 (89.6)               215 (7.9)                                                                  66 (2.4)                                                                   0 (0.0)                                                                    
   Hematological                                                                      2,753 (100.0)          2,319 (84.2)               380 (13.8)                                                                 45 (1.6)                                                                   9 (0.3)                                                                    
   Neurological                                                                       2,681 (100.0)          2,113 (78.8)               393 (14.7)                                                                 149 (5.6)                                                                  26 (1.0)                                                                   
   Urinary and renal                                                                  6,934 (100.0)          5,961 (86.0)               810 (11.7)                                                                 146 (2.1)                                                                  17 (0.2)                                                                   
   Cardiothoracic surgery                                                             6,633 (100.0)          4,075 (61.4)               2,156 (32.5)                                                               304 (4.6)                                                                  98 (1.5)                                                                   
   General surgery                                                                    10,857 (100.0)         8,609 (79.3)               2,045 (18.8)                                                               172 (1.6)                                                                  31 (0.3)                                                                   
   Orthopedic surgery                                                                 3,411 (100.0)          3,091 (90.6)               277 (8.1)                                                                  39 (1.1)                                                                   4 (0.1)                                                                    
   Gynecological                                                                      2,056 (100.0)          1,731 (84.2)               302 (14.7)                                                                 23 (1.1)                                                                   0 (0.0)                                                                    
   Others                                                                             7,139 (100.0)          6,496 (91.0)               525 (7.4)                                                                  102 (1.4)                                                                  16 (0.2)                                                                   
  **Clinical data at admission**                                                                                                                                                                                                                                                                                                                                         
   SBP, mmHg                                                                          122.0 (115.0--135.0)   122.0 (116.0--135.0)       120.0 (110.0--134.0)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}   130.0 (119.0--140.0)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}   128.0 (110.8--140.0)                                                       0.000
   DBP, mmHg                                                                          79.0 (70.0--80.0)      80.0 (70.0--80.0)          77.0 (70.0--80.0)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}      80.0 (70.0--82.0)                                                          75.0 (66.0--80.0)[\*\*](#tfn2-medscimonit-23-2408){ref-type="table-fn"}    0.000
   WBC, 10^9^/L                                                                       6.0 (4.8--7.5)         5.9 (4.8--7.3)             6.4 (4.9--8.6)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}         6.4 (5.0--8.6)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}         7.0 (5.2--10.3)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}        0.000
   Hemoglobin, g/L                                                                    129.0 (116.0--141.0)   130.0 (118.0--142.0)       123.0 (106.0--137.0)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}   125.0 (108.0--138.0)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}   123.0 (100.5--135.5)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}   0.000
   AST, U/L                                                                           20.0 (16.0--28.0)      20.0 (16.0--26.0)          24.0 (17.0--42.0)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}      21.0 (16.0--30.0)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}      25.0 (18.0--44.0)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}      0.000
   ALT, U/L                                                                           19.0 (13.0--30.0)      18.0 (13.0--29.0)          21.0 (13.0--38.0)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}      18.0 (12.0--29.0)                                                          21.0 (13.0--34.0)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}      0.000
   TBIL, μmol/L                                                                       9.2 (6.6--12.9)        9.0 (6.6--12.5)            10.2 (7.0--15.9)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}       9.7 (6.8--14.1)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}        11.4 (7.5--19.2)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}       0.000
   Albumin, g/L                                                                       40.0 (37.0--43.0)      40.0 (37.0--43.0)          38.0 (33.0--41.0)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}      38.0 (34.0--41.0)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}      36.0 (30.0--40.0)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}      0.000
   Glucose, mmol/L                                                                    5.2 (4.7--6.2)         5.2 (4.7--6.2)             5.4 (4.8--6.8)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}         5.2 (4.7--6.3)                                                             5.5 (4.7--7.7)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}         0.000
   SCr, μmol/L                                                                        72.0 (61.0--86.0)      72.0 (61.0--86.0)          72.0 (60.0--88.0)                                                          80.0 (65.0--105.0)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}     78.0 (61.0--101.0)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}     0.000
   BUN, mmol/L                                                                        5.0 (4.0--6.2)         4.9 (4.0--6.1)             5.1 (3.9--6.6)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}         5.9 (4.5--8.5)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}         6.5 (4.9--10.4)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}        0.000
   SUA, mmol/L                                                                        304.0 (244.0--371.0)   306.0 (249.0--371.0)       286.0 (219.0--364.0)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}   326.0 (255.0--415.0)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}   317.0 (230.0--406.0)                                                       0.000
   Na, mmol/L                                                                         141.0 (139.0--143.0)   141.0 (140.0--143.0)       137.0 (135.0--141.0)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}   148.0 (143.0--148.0)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}   141.0 (138.0--145.0)                                                       0.000
   K, mmol/L                                                                          4.0 (3.8--4.3)         4.0 (3.8--4.3)             4.1 (3.8--4.4)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}         4.0 (3.6--4.3)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}         4.0 (3.7--4.4)                                                             0.000
   Cl, mmol/L                                                                         103.0 (101.0--105.0)   103.0 (101.0--105.0)       100.0 (97.0--103.0)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}    107.0 (104.0--110.0)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}   103.0 (99.0--107.0)                                                        0.000
   Mg, mmol/L                                                                         0.91 (0.85--0.97)      0.92 (0.86--0.97)          0.90 (0.83--0.96)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}      0.93 (0.86--1.00)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}      0.91 (0.83--0.99)                                                          0.000
   Ca, mmol/L                                                                         2.31 (2.22--2.39)      2.32 (2.23--2.40)          2.26 (2.14--2.36)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}      2.27 (2.14--2.36)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}      2.24 (2.11--2.34)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}      0.000
   P, mmol/L                                                                          1.13 (0.99--1.26)      1.13 (1.00--1.27)          1.09 (0.93--1.24)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}      1.12 (0.93--1.27)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}      1.08 (0.88--1.26)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}      0.000
   Osmolality, mOsm/L                                                                 301.6 (297.7--305.4)   302.0 (298.6--305.6)       297.0 (290.2--302.5)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}   313.1 (305.1--317.2)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}   303.9 (298.6--313.1)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}   0.000
   CO~2~CP, mmol/L                                                                    24.0 (23.0--26.0)      25.0 (23.0--26.0)          24.0 (22.0--26.0)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}      24.0 (22.0--26.0)[\*\*](#tfn2-medscimonit-23-2408){ref-type="table-fn"}    23.0 (21.0--26.0)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}      0.000
   AG, mmol/L                                                                         14.0 (12.0--15.0)      14.0 (12.0--15.0)          14.0 (12.0--16.0)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}      15.0 (13.0--17.0)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}      15.0 (13.0--17.0)[\#](#tfn3-medscimonit-23-2408){ref-type="table-fn"}      0.000

*P*\<0.05;

*P*\<0.01;

*P*\<0.001;

Row N%.

The normonatremia group served as the reference when comparing between two groups. BMI -- body mass index; SBP -- systolic blood pressure; DBP -- diastolic blood pressure; WBC -- white blood cell; ALT -- alanine aminotransferase; AST -- aspartate aminotransferase; TBIL -- total bilirubin; SCr -- serum creatinine; BUN -- blood urea nitrogen; SUA -- serum uric acid; CO~2~CP -- carbon dioxide combining power; AG -- anion gap.

###### 

Characteristics of patients with community-acquired or hospital-acquired dysnatremia.

  Variable                                                                           Hyponatremia           Hypernatremia                                                                
  ---------------------------------------------------------------------------------- ---------------------- ---------------------- ------- ---------------------- ---------------------- -------
  **Age, year**                                                                      63.0 (52.0--72.0)      60.0 (50.0--68.0)      0.000   64.0 (54.0--74.3)      63.0 (54.0--73.5)      0.515
  **\>65, n (%)**                                                                    2,969 (42.1)           2,680 (32.8)           0.000   386 (45.4)             365 (43.6)             0.456
  **Male sex, n (%)**                                                                4,845 (68.6)           5,422 (66.3)           0.002   496 (58.4)             472 (56.4)             0.415
  **BMI, kg/m2**                                                                     22.4 (20.0--24.9)      22.8 (20.7--25.3)      0.010   23.4 (20.6--25.7)      23.6 (21.8--26.3)      0.731
  **Underlying diseases, n(%)**[§](#tfn6-medscimonit-23-2408){ref-type="table-fn"}                                                 0.000                                                 0.000
   Cancer                                                                            1,577 (37.8)           2,600 (62.2)           0.000   73 (38.8)              115 (61.2)             0.001
   Pulmonary                                                                         956 (83.1)             195 (16.9)             0.000   66 (61.1)              42 (38.9)              0.021
   Cardiovascular                                                                    802 (55.5)             643 (44.5)             0.000   180 (73.5)             65 (26.5)              0.000
   Digestive                                                                         1,016 (74.5)           347 (25.5)             0.000   71 (71.0)              29 (29.0)              0.000
   Endocrine                                                                         151 (70.2)             64 (29.8)              0.000   37 (56.1)              29 (43.9)              0.347
   Hematological                                                                     211 (55.5)             169 (44.5)             0.000   28 (62.2)              17 (37.8)              0.107
   Neurological                                                                      189 (48.1)             204 (51.9)             0.476   67 (45.0)              82 (55.0)              0.166
   Urinary and renal                                                                 458 (56.5)             352 (43.5)             0.000   67 (45.9)              79 (54.1)              0.256
   Cardiothoracic surgery                                                            299 (13.9)             1,857 (86.1)           0.000   81 (26.6)              223 (73.4)             0.000
   General surgery                                                                   728 (35.6)             1,317 (64.4)           0.000   74 (43.0)              98 (57.0)              0.042
   Orthopedic surgery                                                                137 (49.5)             140 (50.5)             0.291   22 (56.4)              17 (43.6)              0.446
   Gynecological                                                                     139 (46.0)             163 (54.0)             0.917   13 (56.5)              10 (43.5)              0.553
   Others                                                                            396 (75.4)             129 (24.6)             0.000   71 (69.6)              31 (30.4)              0.000
  **Clinical data at admission**                                                                                                                                                         
   SBP, mmHg                                                                         120.0 (110.0--135.0)   120.0 (111.0--132.0)   0.596   130.0 (120.0--140.0)   130.0 (118.0--140.0)   0.825
   DBP, mmHg                                                                         76.0 (70.0--80.0)      78.0 (70.0--80.0)      0.000   80.0 (70.0--81.0)      80.0 (69.0--82.0)      0.109
   WBC, 10^9^/L                                                                      7.1 (5.2--9.8)         6.0 (4.7--7.6)         0.000   6.3 (4.8--8.2)         6.6 (5.2--8.9)         0.002
   Hemoglobin, g/L                                                                   117.0 (99.0--132.0)    128.0 (113.0--140.0)   0.000   126.0 (111.0--139.0)   123.0 (106.0--138.0)   0.025
   AST, U/L                                                                          26.0 (17.0--49.0)      23.0 (17.0--37.0)      0.000   20.0 (16.0--29.0)      21.0 (16.0--31.0)      0.296
   ALT, U/L                                                                          22.0 (13.0--42.0)      21.0 (13.0--36.0)      0.000   18.0 (13.0--29.0)      18.0 (12.0--30.0)      0.421
   TBIL, μmol/L                                                                      10.3 (6.6--18.0)       10.1 (7.2--14.7)       0.000   9.4 (6.9--13.1)        10.2 (6.8--15.2)       0.009
   Albumin, g/L                                                                      36.0 (31.0--40.0)      39.0 (35.0--42.0)      0.000   38.0 (34.0--41.0)      37.0 (33.0--40.0)      0.002
   Glucose, mmol/L                                                                   5.9 (5.0--7.9)         5.2 (4.7--6.2)         0.000   5.2 (4.7--6.2)         5.2 (4.7--6.4)         0.277
   SCr, μmol/L                                                                       71.0 (58.0--90.0)      73.0 (61.0--87.0)      0.000   80.0 (65.0--101.0)     79.0 (65.0--109.0)     0.526
   BUN, mmol/L                                                                       5.0 (3.8--7.0)         5.1 (4.0--6.4)         0.455   5.6 (4.4--8.3)         6.1 (4.6--8.8)         0.081
   SUA, mmol/L                                                                       267.0 (195.0--356.0)   298.0 (239.0--369.0)   0.000   328.0 (256.0--412.0)   323.5 (255.0--417.3)   0.748
   Na, mmol/L                                                                        135.0 (133.0--136.0)   140.0 (139.0--142.0)   0.000   148.0 (148.0--150.0)   143.0 (141.0--144.0)   0.000
   K, mmol/L                                                                         4.1 (3.8--4.4)         4.1 (3.8--4.3)         0.000   4.0 (3.7--4.3)         3.9 (3.6--4.2)         0.018
   Cl, mmol/L                                                                        97.0 (94.0--99.0)      102.0 (100.0--104.0)   0.000   109.0 (107.0--111.0)   104.0 (102.0--106.0)   0.000
   Mg, mmol/L                                                                        0.89 (0.82--0.96)      0.90 (0.84--0.97)      0.000   0.94 (0.87--1.01)      0.92 (0.85--0.99)      0.000
   Ca, mmol/L                                                                        2.23 (2.11--2.35)      2.28 (2.17--2.37)      0.000   2.28 (2.18--2.37)      2.26 (2.11--2.36)      0.001
   P, mmol/L                                                                         1.05 (0.88--1.22)      1.12 (0.97--1.26)      0.000   1.12 (0.95--1.26)      1.11 (0.92--1.29)      0.880
   Osmolality, mOsm/L                                                                289.0 (285.2--293.4)   300.7 (297.0--304.4)   0.000   316.2 (314.1--321.1)   305.2 (301.3--309.7)   0.000
   CO~2~CP, mmol/L                                                                   23.0 (21.0--25.0)      24.0 (22.0--26.0)      0.000   25.0 (23.0--27.0)      24.0 (22.0--26.0)      0.000
   AG, mmol/L                                                                        14.0 (12.0--16.0)      14.0 (12.0--16.0)      0.000   15.0 (13.0--16.0)      15.0 (13.0--17.0)      0.866

Row N%.

CA -- community-acquired; HA -- hospital-acquired; BMI -- body mass index; SBP -- systolic blood pressure; DBP -- diastolic blood pressure; WBC -- white blood cell; ALT -- alanine aminotransferase; AST -- aspartate aminotransferase; TBIL -- total bilirubin; SCr -- serum creatinine; BUN -- blood urea nitrogen; SUA -- serum uric acid; CO~2~CP -- carbon dioxide combining power; AG -- anion gap.

###### 

Characteristics of selected patients with improved, persistent and mixed dysnatremia.

  Variable                                                                            Hyponatremia           Hypernatremia          Mixed dysnatremia                                                                                                   
  ----------------------------------------------------------------------------------- ---------------------- ---------------------- ------------------- -------------------- -------------------- ------- ---------------------- ---------------------- -------
  **Age, year**                                                                       61.0 (50.0--70.0)      61.0 (52.0--70.0)      0.028               63.3±15.1            63.4±15.5            0.910   70.4±15.6              61.8±14.8              0.000
  **\>65, n (%)**                                                                     1,918 (36.8)           3,731 (37.2)           0.601               375 (43.7)           376 (45.4)           0.468   67 (65.7)              78 (42.6)              0.000
  **Male sex, n (%)**                                                                 3,348 (64.2)           6,919 (69.0)           0.000               476 (55.4)           492 (59.4)           0.096   65 (63.7)              117 (63.9)             0.972
  **BMI, kg/m^2^**                                                                    22.9±3.7               22.9±3.9               0.743               23.3±4.4             24.1±3.7             0.214   21.8±3.9               23.6±3.5               0.249
  **Underlying diseases, n (%)**[§](#tfn8-medscimonit-23-2408){ref-type="table-fn"}                          0.000                                                           0.000                                               0.000                  
   Cancer                                                                             1,391 (33.3)           2,786 (66.7)           0.144               124 (66.0)           64 (34.0)            0.000   12 (36.4)              21 (63.6)              0.942
   Pulmonary                                                                          292 (25.4)             859 (74.6)             0.000               41 (38.0)            67 (62.0)            0.005   6 (40.0)               9 (60.0)               0.727
   Cardiovascular                                                                     495 (34.3)             950 (65.7)             0.972               99 (40.4)            146 (59.6)           0.000   5 (22.7)               17 (77.3)              0.183
   Digestive                                                                          324 (23.8)             1039 (76.2)            0.000               27 (27.0)            73 (73.0)            0.000   7 (50.0)               7 (50.0)               0.255
   Endocrine                                                                          113 (52.6)             102 (47.4)             0.000               38 (57.6)            28 (42.4)            0.270   0                      0                      --
   Hematological                                                                      146 (38.4)             234 (61.6)             0.080               14 (31.1)            31 (68.9)            0.007   5 (55.6)               4 (44.4)               0.209
   Neurological                                                                       165 (42.0)             228 (58.0)             0.001               80 (53.7)            69 (46.3)            0.478   14 (53.8)              12 (46.2)              0.044
   Urinary and renal                                                                  325 (40.1)             485 (59.9)             0.000               49 (33.6)            97 (66.4)            0.000   11 (64.7)              6 (35.3)               0.010
   Cardiothoracic surgery                                                             700 (32.5)             1,456 (67.5)           0.065               222 (73.0)           82 (27.0)            0.000   17 (17.3)              81 (82.7)              0.000
   General surgery                                                                    885 (43.3)             1,160 (56.7)           0.000               113 (65.7)           59 (34.3)            0.000   11 (35.5)              20 (64.5)              0.970
   Orthopedic surgery                                                                 101 (36.5)             176 (63.5)             0.426               11 (28.2)            28 (71.8)            0.004   3 (75.0)               1 (25.0)               0.099
   Gynecological                                                                      84 (27.8)              218 (72.2)             0.018               15 (65.2)            8 (34.8)             0.167   0                      0                      --
   Others                                                                             193 (36.8)             332 (63.2)             0.211               26 (25.5)            76 (74.5)            0.000   11 (68.8)              5 (31.2)               0.005
  **Clinical data at admission**                                                                                                                                                                                                                        
   SBP, mmHg                                                                          124.3±17.8             124.2±17.4             0.719               129.0±20.1           129.4±19.5           0.701   127.3±19.3             129.9±25.2             0.503
   DBP, mmHg                                                                          75.3±11.0              75.9±12.4              0.004               75.7±11.9            78.5±32.7            0.033   74.1±12.1              75.0±13.6              0.624
   WBC, 10^9^/L                                                                       6.5 (5.0--8.9)         6.3 (4.8--8.4)         0.000               8.0±11.1             7.6±4.6              0.325   8.4 (5.8--12.4)        6.4 (5.0--9.1)         0.001
   Hemoglobin, g/L                                                                    120.6±24.3             120.2±23.8             0.260               121.2±25.1           120.5±26.0           0.553   108.8±27.2             121.4±27.2             0.000
   AST, U/L                                                                           23.0 (17.0--39.0)      24.0 (17.0--43.0)      0.000               21.0 (16.0--31.0)    20.0 (16.0--29.0)    0.035   118.1±575.9            65.5±241.1             0.283
   ALT, U/L                                                                           21.0 (13.0--37.3)      22.0 (13.0--39.0)      0.008               47.9±334.6           36.1±84.4            0.321   46.3±83.6              39.8±77.1              0.512
   TBIL, μmol/L                                                                       10.1 (6.9--15.6)       10.3 (7.0--16.1)       0.045               14.9±27.9            15.3±41.8            0.795   10.5 (6.9--18.9)       11.7 (8.3--19.5)       0.427
   Albumin, g/L                                                                       38.0 (33.0--41.0)      38.0 (33.0--41.0)      0.204               37.0 (34.0--40.0)    38.0 (34.0--41.0)    0.106   32.9±6.2               36.3±6.1               0.000
   Glucose, mmol/L                                                                    6.5±3.4                6.5±3.2                0.277               6.1±2.8              6.1±2.7              0.978   7.0±3.3                6.6±3.3                0.418
   SCr, μmol/L                                                                        73.0 (60.0--89.0)      72.0 (60.0--88.0)      0.006               79.0 (65.0--106.0)   80.0 (65.0--104.0)   0.641   75.5 (58.2--110.3)     79.0 (62.0--100.0)     0.509
   BUN, mmol/L                                                                        5.0 (3.8--6.7)         5.1 (3.9--6.6)         0.873               5.9 (4.5--8.6)       5.8 (4.5--8.5)       0.629   9.8±9.1                8.6±7.2                0.222
   SUA, mmol/L                                                                        285.0 (217.0--366.0)   286.0 (220.0--363.0)   0.664               346.1±137.1          351.2±145.5          0.468   307.3±166.1            348.1±147.8            0.034
   Na, mmol/L                                                                         138.0±4.2              137.1±4.5              0.000               145.5±4.9            146.8±5.0            0.000   135.9±4.6              144.4±4.6              0.000
   K, mmol/L                                                                          4.1 (3.8--4.3)         4.1 (3.8--4.4)         0.000               3.9±0.6              4.0±0.6              0.028   4.2±0.7                4.0±0.5                0.005
   Cl, mmol/L                                                                         101.0 (97.0--103.0)    100.0 (96.0--103.0)    0.000               106.4±5.7            107.4±5.7            0.000   98.4±5.4               105.7±5.5              0.000
   Mg, mmol/L                                                                         0.90 (0.83--0.97)      0.90 (0.83--0.96)      0.354               0.93±0.14            0.95±0.15            0.009   0.92 (0.83--1.00)      0.90 (0.83--0.98)      0.418
   Ca, mmol/L                                                                         2.24 (2.12--2.35)      2.27 (2.16--2.37)      0.000               2.22±0.20            2.27±0.22            0.000   2.20±0.19              2.22±0.18              0.548
   P, mmol/L                                                                          1.08 (0.89--1.24)      1.10 (0.94--1.24)      0.000               1.10±0.34            1.15±0.42            0.029   1.07±0.39              1.11±0.38              0.383
   Osmolality, mOsm/L                                                                 297.5±9.4              295.7±9.6              0.000               312.3±13.4           315.4±13.7           0.000   297.0 (290.9--300.7)   308.0 (302.1--316.9)   0.000
   CO~2~CP, mmol/L                                                                    24.0 (22.0--26.0)      24.0 (22.0--26.0)      0.000               23.1±5.5             22.6±6.2             0.179   22.5±4.3               23.7±4.0               0.019
   AG, mmol/L                                                                         14.0 (12.0--16.0)      14.0 (12.0--16.0)      0.000               14.9±3.8             15.1±4.1             0.187   15.2±4.1               15.2±3.5               0.995

Row N%.

BMI -- body mass index; SBP -- systolic blood pressure; DBP -- diastolic blood pressure; WBC -- white blood cell; ALT -- alanine aminotransferase; AST -- aspartate aminotransferase; TBIL -- total bilirubin; SCr -- serum creatinine; BUN -- blood urea nitrogen; SUA -- serum uric acid; CO~2~CP -- carbon dioxide combining power; AG -- anion gap.

###### 

Final multiple logistic regression analysis of dysnatremia as independent risk factors for hospital mortality.

  Variable                                                          Multiple logistic analysis   
  ----------------------------------------------------------------- ---------------------------- -------
  **Model 1**[§](#tfn10-medscimonit-23-2408){ref-type="table-fn"}                                
   Hyponatremia                                                     2.225 (1.857--2.667)         0.000
   Hypernatremia                                                    13.387 (10.642--16.840)      0.000
   Mixed dysnatremia                                                22.344 (15.709--31.783)      0.000
  **Model 2**[§](#tfn10-medscimonit-23-2408){ref-type="table-fn"}                                
   CA-hyponatremia                                                  1.950 (1.552--2.451)         0.000
   HA-hyponatremia                                                  2.567 (2.087--3.156)         0.000
   CA-hypernatremia                                                 8.827 (6.141--12.689)        0.000
   HA-hypernatremia                                                 16.216 (12.588--20.888)      0.000
   Mixed dysnatremia                                                21.387 (14.992--30.510)      0.000
  **Model 3**[§](#tfn10-medscimonit-23-2408){ref-type="table-fn"}                                
   Improved hyponatremia                                            2.561 (2.062--3.182)         0.000
   Persistent hyponatremia                                          2.016 (1.649--2.465)         0.000
   Improved hypernatremia                                           6.755 (4.847--9.413)         0.000
   Persistent hypernatremia                                         22.292 (17.041--29.162)      0.000
   "Hypo to hyper" mixed dysnatremia                                56.884 (35.098--92.193)      0.000
   "Hyper to hypo" mixed dysnatremia                                6.629 (3.499--12.557)        0.000

Normonatremia as the reference.

CA -- community acquired; HA -- hospital acquired; OR -- odds ratio; CI -- confidence interval.

###### 

Final multiple logistic regression analysis of other independent risk factors for hospital mortality.

  Variable                                                                       Model 1                Model 2   Model 3                                               
  ------------------------------------------------------------------------------ ---------------------- --------- ---------------------- ------- ---------------------- -------
  Age, per year increase                                                         1.048 (1.043--1.054)   0.000     1.049 (1.043--1.054)   0.000   1.048 (1.043--1.054)   0.000
  Male sex                                                                       1.197 (1.035--1.384)   0.015     1.197 (1.035--1.384)   0.015   1.199 (1.037--1.388)   0.015
  BMI \<18.5 kg/m^2^[§](#tfn12-medscimonit-23-2408){ref-type="table-fn"}         3.155 (1.966--5.063)   0.000     3.076 (1.912--4.949)   0.000   3.240 (2.018--5.201)   0.000
  DBP \>90 mmHg[§](#tfn12-medscimonit-23-2408){ref-type="table-fn"}              1.470 (1.120--1.930)   0.006     1.473 (1.121--1.934)   0.005   1.468 (1.118--1.927)   0.006
  Hypochloridemia[§](#tfn12-medscimonit-23-2408){ref-type="table-fn"}            1.998 (1.668--2.393)   0.000     2.179 (1.785--2.659)   0.000   2.003 (1.671--2.402)   0.000
  CO2CP \>29 mmol/L[§](#tfn12-medscimonit-23-2408){ref-type="table-fn"}          1.902 (1.452--2.491)   0.000     1.927 (1.467--2.533)   0.000   1.898 (1.447--2.490)   0.000
  AG \>16 mmol/L[§](#tfn12-medscimonit-23-2408){ref-type="table-fn"}             1.717 (1.430--2.062)   0.000     1.698 (1.412--2.043)   0.000   1.720 (1.432--2.067)   0.000
  ALT, per 50U/L increase                                                        1.030 (1.015--1.046)   0.000     1.030 (1.014--1.046)   0.000   1.031 (1.015--1.047)   0.000
  TBIL, per 20 μmol/L increase                                                   1.038 (1.015--1.046)   0.001     1.037 (1.014--1.046)   0.001   1.039 (1.016--1.063)   0.001
  Albumin, per 5 g/L decrease                                                    1.418 (1.328--1.514)   0.000     1.424 (1.334--1.521)   0.000   1.426 (1.335--1.523)   0.000
  Hemoglobin (90--119 g/L)[§](#tfn12-medscimonit-23-2408){ref-type="table-fn"}   1.451 (1.228--1.715)   0.000     1.454 (1.230--1.719)   0.000   1.446 (1.222--1.710)   0.000
  Hemoglobin (60--89 g/L)[§](#tfn12-medscimonit-23-2408){ref-type="table-fn"}    1.871 (1.491--2.348)   0.000     1.893 (1.508--2.376)   0.000   1.865 (1.484--2.343)   0.000
  Hemoglobin (\<60 g/L)[§](#tfn12-medscimonit-23-2408){ref-type="table-fn"}      4.174 (2.961--5.883)   0.000     4.264 (3.027--6.007)   0.000   4.099 (2.902--5.791)   0.000
  WBC \>12.0×10^9^/L[§](#tfn12-medscimonit-23-2408){ref-type="table-fn"}         2.252 (1.874--2.705)   0.000     2.257 (1.878--2.712)   0.000   2.246 (1.868--2.701)   0.000
  BUN, per 10 mg/dl increase                                                     1.281 (1.215--1.351)   0.000     1.277 (1.211--1.347)   0.000   1.282 (1.067--1.540)   0.000
  SCr, per 0.5 mg/dl increase                                                    0.935 (0.909--0.961)   0.000     0.932 (0.906--0.959)   0.000   0.932 (0.906--0.959)   0.000
  Hypouricemia[§](#tfn12-medscimonit-23-2408){ref-type="table-fn"}               1.296 (1.079--1.555)   0.005     1.299 (1.082--1.560)   0.005   1.282 (1.067--1.540)   0.008
  Hyperuricemia[§](#tfn12-medscimonit-23-2408){ref-type="table-fn"}              1.536 (1.279--1.846)   0.000     1.523 (1.267--1.830)   0.000   1.546 (1.285--1.859)   0.000

Normal range as the reference.

BMI -- body mass index; DBP -- diastolic blood pressure; CO~2~CP -- carbon dioxide combining power; AG -- anion gap; ALT -- alanine aminotransferase; TBIL -- total bilirubin; WBC -- white blood cell; BUN -- blood urea nitrogen; SCr -- serum creatinine; OR -- odds ratio; CI -- confidence interval.
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